Feb 6, 2024
Maker of recalled sleep apnea machines agrees to halt sales in US
The company behind a global recall of sleep apnea machines said Monday it will stop selling the devices in the U.S., under a tentative agreement with regulators that could cost the manufacturer nearly $400 million.
Jan 29, 2024
Bayer ordered to pay $2.25 billion in latest Roundup trial
Bayer (BAYGn.DE), opens new tab was ordered on Friday to pay $2.25 billion to a Pennsylvania man who said he developed cancer from exposure to the company's Roundup weedkiller, the man's attorneys said.
Jan 18, 2024
3M Begins to Pay Out $253 Million to Veterans, Military Service Members for Defective Ear Plugs
Multinational conglomerate 3M is beginning to pay out over $250 million dollars to veterans and military service members for defective ear plugs.
Nov 29, 2023
DuPont, Chemours, Corteva Reach a $110 Million ‘Forever Chemicals’ Settlement in Ohio
Chemours, Dupont De Nemours and Corteva have reached a settlement agreement with the U.S. state of Ohio for $110 million to resolve claims associated with toxic “forever chemicals”, the companies said on Wednesday.
Nov 20, 2023
Bayer Must Pay $1.56 Billion in Latest U.S. Trial Loss Over Roundup Weedkiller
A Missouri jury ordered Bayer to pay $1.56 billion to four plaintiffs who claimed the company’s Roundup weedkiller caused injuries including cancer, a verdict that could intensify investor pressure on the German drugs and agricultural chemicals company to change its legal strategy.
Oct 30, 2023
Bayer ordered to pay $175 million in latest Roundup cancer trial
Oct 27 (Reuters) - A Philadelphia jury on Friday found Bayer AG (BAYGn.DE) liable in a case brought by a retired restaurant owner who claimed his cancer was due to exposure to the company's Roundup weed killer, and ordered Bayer to pay him $175 million in damages, the man's lawyers said.